These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10758645)

  • 1. [Tanakan in the treatment of perinatal injuries of the central nervous system].
    Shprakh VV; Saiutina SB; Revezova TV; Pak KO; Arbatskaia OIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(3):33-5. PubMed ID: 10758645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of tanakan on central nervous system function in patients with the residual manifestations of stroke].
    Kuznetsova SM; Glazovskaia II; Kuznetsov VV
    Lik Sprava; 1997; (6):132-4. PubMed ID: 9589957
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Ginkgo biloba extract on somatosensory evoked potential, nitric oxide levels in serum and brain tissue in rats with cerebral vasospasm after subarachnoid hemorrhage.
    Sun BL; Xia ZL; Yang MF; Qiu PM
    Clin Hemorheol Microcirc; 2000; 23(2-4):139-44. PubMed ID: 11321433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical efficacy of tanakan in patients with stage-I atherosclerotic circulatory encephalopathy].
    Rudenko AE; Lushchik UB; Dzhumik VA
    Lik Sprava; 1997; (2):99-101. PubMed ID: 9333499
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of special Ginkgo biloba extract for cognitive disorders in the elderly].
    Simányi M
    Wien Med Wochenschr; 1999; 149(8-10):231-4. PubMed ID: 10483688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A symbol of life force: Ginkgo biloba L].
    Simányi M; Swoboda H; Kopp B
    Wien Med Wochenschr; 1999; 149(8-10):229-30. PubMed ID: 10483687
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cholinesterase inhibitor and ginkgo extracts in therapy of dementia. A comparison of effectiveness based on controlled studies].
    Wettstein A
    Fortschr Med; 1999 Feb; 117(5):48-9. PubMed ID: 10095316
    [No Abstract]   [Full Text] [Related]  

  • 8. [The efficacy of treating cerebral ischemia due to changes in the major cerebral arteries by using the preparation Tanakan (EGB 761)].
    Dziak LA; Golik VA
    Lik Sprava; 1998 Aug; (6):125-7. PubMed ID: 9844896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new approach to the treatment of patients with circulatory encephalopathy].
    Kupnovyts'ka MIu; Lushchyk UB; Herasymchuk RD; Chmyr HS; Iatsyshyn RI; Dubanovych LB
    Lik Sprava; 1997; (5):142-5. PubMed ID: 9491724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of tanakan on blood lipid peroxidation and platelet aggregation properties in patients with insulin-dependent diabetes mellitus].
    Balashova TS; Kubatiev AA
    Ter Arkh; 1998; 70(12):49-54. PubMed ID: 10067254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tanakan in the treatment of primary manifestations of insufficiency of brain blood supply].
    Timerbaeva SL; Suslina ZA; Bodareva EA; Fedin PA; Korepina OS; Pervosvanskiĭ BE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(8):24-8. PubMed ID: 10983363
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience in clinical use of tanakan in the treatment of the syndrome of mild cognitive impairment].
    Gavrilova SI; Fedorova IaB; Roshchina IF; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(10):42-6. PubMed ID: 17117673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of efficiency of ceraxon in the treatment of lag psychomotor development of children with hypoxic-ischemic lesions of central nervous system].
    Rubtsova IeI; Klimova TM; Hechko KhA
    Wiad Lek; 2014; 67(2 Pt 2):248-50. PubMed ID: 25796838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antihypoxic and antioxidant action of medicinal plants as the basis for their use in destructive brain diseases].
    Pospelova ML; Barnaulov OD
    Fiziol Cheloveka; 2000; 26(1):100-6. PubMed ID: 10752298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of tanakan on psychophysiological status of patients with asthenic disorders].
    Neznamov GG; Teleshova ES; Siuniakov SA; Morozov IS; Davydova IA; Zhirnov EN
    Eksp Klin Farmakol; 2002; 65(1):19-23. PubMed ID: 12025777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of asthenic disorders with tanakan].
    Milopol'skaia IM
    Ter Arkh; 2001; 73(10):45-7. PubMed ID: 11763515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficiency of mexidol during perinatal encephalopathy in early age children].
    Natriashvili GD; Kapanadze NB; Natriashvili SG
    Georgian Med News; 2005 Jun; (123):35-9. PubMed ID: 16052053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of extract of Ginkgo biloba on spasms of the basilar artery and cerebral microcirculatory perfusion in rats with subarachnoid hemorrhage.
    Sun BL; Zhang J; Wang XC; Xia ZL; Yang MF; Zhang SM; Ye WJ; Yuan H
    Clin Hemorheol Microcirc; 2003; 29(3-4):231-8. PubMed ID: 14724346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurasthenia as a variant of the asthenic syndrome: a pharmacotherapeutic analysis modelled on tanakan therapy].
    Krasnov VN; Vel'tishev DIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(7):37-40. PubMed ID: 10441850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of placebos for double-blind clinical trials. Experience with a phytopharmaceutical.
    Knipschild PG; Hoerr R; Oschmann R; van Rossum E; van Dongen MC
    Arzneimittelforschung; 1998 Oct; 48(10):1033-6. PubMed ID: 9825123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.